February 14, 2022
Authored and Edited by Soniya Shah; Esther H. Lim; Kara Specht; Elizabeth D. Ferrill
In PlasmaCAM, Inc. v. CNCElectronics, LLC, No. 21-1689 (Fed. Cir. Feb. 3, 2022), the Federal Circuit reversed and remanded the district court’s judgment ordering CNC to execute Plasmacam’s version of the settlement agreement.
The patent-in-suit is directed to a plasma cutting system, to which Plasmacam has an executive license. Plasmacam accused CNC of infringement. The parties later notified the district court that they reached a settlement agreement; however, the parties could not agree on the scope of the release. CNC advocated for a broad release of all past and future claims, not just those specifically accused of infringement. The district court ordered CNC to execute the settlement agreement using Plasmacam’s proposed narrow scope, releasing only past and future claims for products accused of infringement.
In a split decision, the Federal Circuit held that “the district court committed clear error” when ordering CNC to execute the settlement based on Plasmacam’s terms, finding that email correspondence between the parties “establishes that Plasmacam ultimately agreed to CNC’s proposed Covered Products definition” and released CNC from future claims of infringement. Judge Newman dissented, finding that there was never an agreement between the parties.
Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
INCONTESTABLE® Blog
April 19, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.